Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-12-04 Sale | 2023-12-04 7:41 pm | AMGEN INC | AMGN | Grygiel Nancy A. SVP & CCO | 2,096 | $273.03 | $572,276 | 10,972 (Indirect Direct) | View |
2023-11-08 Sale | 2023-11-13 8:30 pm | AMGEN INC | AMGN | Graham Jonathan P EVP, Gen. Counsel & Secy. | 10,000 | $272.81 | $2,728,136 | 28,078 (Direct) | View |
2023-09-19 Purchase | 2023-09-19 7:52 pm | Neumora Therapeutics Inc. | NMRA | AMGEN INC 10% Owner | 1,764,705 | $17 | $29,999,985 | 35,368,653 (Direct) | View |
2023-08-10 Sale | 2023-08-11 6:13 pm | AMGEN INC | AMGN | Gordon Murdo EVP, Global Commercial Ops | 9,558 | $262.43 | $2,508,306 | 44,308 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-03-18 Tax Withholding | 2024-03-20 8:12 pm | N/A N/A | AMGEN INC | AMGN | Santos Esteban EVP, Operations | 6,137 | $268.87 | 71,070 (Direct) | View |
2024-03-18 Tax Withholding | 2024-03-20 8:11 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP & Chief Technology Officer | 6,202 | $268.87 | 60,666 (Direct) | View |
2024-03-18 Tax Withholding | 2024-03-20 8:10 pm | N/A N/A | AMGEN INC | AMGN | Miller Derek SVP, Human Resources | 475 | $268.87 | 8,419 (Direct) | View |
2024-03-18 Tax Withholding | 2024-03-20 8:09 pm | N/A N/A | AMGEN INC | AMGN | Khosla Rachna SVP, Business Development | 438 | $268.87 | 8,190 (Direct) | View |
2024-03-18 Tax Withholding | 2024-03-20 8:07 pm | N/A N/A | AMGEN INC | AMGN | Grygiel Nancy A. SVP & CCO | 703 | $268.87 | 12,320 (Direct) | View |
2024-03-18 Tax Withholding | 2024-03-20 8:05 pm | N/A N/A | AMGEN INC | AMGN | Griffith Peter H. EVP & CFO | 5,168 | $268.87 | 34,710 (Direct) | View |
2024-03-18 Tax Withholding | 2024-03-20 8:04 pm | N/A N/A | AMGEN INC | AMGN | Graham Jonathan P EVP & Gen. Counsel & Secy. | 5,879 | $268.87 | 34,232 (Direct) | View |
2024-03-18 Tax Withholding | 2024-03-20 8:00 pm | N/A N/A | AMGEN INC | AMGN | Gordon Murdo EVP, Global Commercial Ops | 6,461 | $268.87 | 51,321 (Direct) | View |
2024-03-18 Tax Withholding | 2024-03-20 7:59 pm | N/A N/A | AMGEN INC | AMGN | Busch Matthew C. VP, Finance & CAO | 146 | $268.87 | 4,670 (Direct) | View |
2024-03-18 Tax Withholding | 2024-03-20 7:58 pm | N/A N/A | AMGEN INC | AMGN | Bradway Robert A Chairman, CEO and President | 20,560 | $268.87 | 664,077 (Direct) | View |
2024-03-06 Option Award | 2024-03-08 5:34 pm | N/A N/A | AMGEN INC | AMGN | Santos Esteban EVP, Operations | 12,278 | $0 | 76,975 (Direct) | View |
2024-03-06 Option Award | 2024-03-08 5:32 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP & Chief Technology Officer | 12,407 | $0 | 66,653 (Direct) | View |
2024-03-06 Option Award | 2024-03-08 5:31 pm | N/A N/A | AMGEN INC | AMGN | Miller Derek SVP, Human Resources | 1,311 | $0 | 8,863 (Direct) | View |
2024-03-06 Option Award | 2024-03-08 5:30 pm | N/A N/A | AMGEN INC | AMGN | Khosla Rachna SVP, Business Development | 1,256 | $0 | 8,597 (Direct) | View |
2024-03-06 Option Award | 2024-03-08 5:29 pm | N/A N/A | AMGEN INC | AMGN | Grygiel Nancy A. SVP & CCO | 1,954 | $0 | 12,964 (Direct) | View |
2024-03-06 Option Award | 2024-03-08 5:27 pm | N/A N/A | AMGEN INC | AMGN | Griffith Peter H. EVP & CFO | 10,338 | $0 | 39,250 (Direct) | View |
2024-03-06 Option Award | 2024-03-08 5:26 pm | N/A N/A | AMGEN INC | AMGN | Graham Jonathan P EVP & Gen. Counsel & Secy. | 11,760 | $0 | 39,925 (Direct) | View |
2024-03-06 Option Award | 2024-03-08 5:25 pm | N/A N/A | AMGEN INC | AMGN | Gordon Murdo EVP, Global Commercial Ops | 12,924 | $0 | 57,569 (Direct) | View |
2024-03-06 Option Award | 2024-03-08 5:24 pm | N/A N/A | AMGEN INC | AMGN | Busch Matthew C. VP, Finance & CAO | 418 | $0 | 4,799 (Direct) | View |
2024-03-06 Option Award | 2024-03-08 5:23 pm | N/A N/A | AMGEN INC | AMGN | Bradway Robert A Chairman, CEO and President | 41,133 | $0 | 683,910 (Direct) | View |
2024-02-09 Option Award | 2024-02-12 7:50 pm | N/A N/A | AMGEN INC | AMGN | Bradner James E. EVP, R&D, & Chief Sci. Officer | 22,393 | $0 | 22,393 (Direct) | View |
2023-11-28 Gift | 2023-11-29 8:44 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 165 | $0 | 54,164 (Direct) | View |
2023-11-05 Tax Withholding | 2023-11-07 8:20 pm | N/A N/A | AMGEN INC | AMGN | Miller Derek SVP, Human Resources | 66 | $269.86 | 7,533 (Direct) | View |
2023-11-05 Tax Withholding | 2023-11-07 8:16 pm | N/A N/A | AMGEN INC | AMGN | Khosla Rachna SVP, Business Development | 317 | $269.86 | 7,323 (Direct) | View |
2023-11-05 Tax Withholding | 2023-11-07 8:15 pm | N/A N/A | AMGEN INC | AMGN | Grygiel Nancy A. SVP & CCO | 249 | $269.86 | 13,068 (Direct) | View |
2023-11-05 Tax Withholding | 2023-11-07 8:12 pm | N/A N/A | AMGEN INC | AMGN | Busch Matthew C. VP, Finance & CAO | 249 | $269.86 | 4,367 (Direct) | View |
2023-11-03 Option Award | 2023-11-07 8:10 pm | N/A N/A | AMGEN INC | AMGN | ISHRAK OMAR Director | 241 | $0 | 3,813 (Direct) | View |
2023-11-03 Option Award | 2023-11-07 8:09 pm | N/A N/A | AMGEN INC | AMGN | HOLLEY CHARLES M Director | 296 | $0 | 9,835 (Direct) | View |
2023-11-03 Option Award | 2023-11-07 8:06 pm | N/A N/A | AMGEN INC | AMGN | Drake Michael V Director | 241 | $0 | 2,301 (Direct) | View |
2023-11-01 Tax Withholding | 2023-11-03 7:44 pm | N/A N/A | AMGEN INC | AMGN | Griffith Peter H. EVP & CFO | 3,502 | $255.7 | 28,820 (Direct) | View |
2023-11-01 Tax Withholding | 2023-11-03 7:43 pm | N/A N/A | AMGEN INC | AMGN | Graham Jonathan P EVP, Gen. Counsel & Secy. | 1,751 | $255.7 | 38,078 (Direct) | View |
2023-09-19 Conversion | 2023-09-19 7:52 pm | N/A N/A | Neumora Therapeutics Inc. | NMRA | AMGEN INC 10% Owner | 67,207,896 | $0 | 35,368,653 (Direct) | View |
Ownership | 2023-09-14 6:58 pm | N/A N/A | Neumora Therapeutics Inc. | NMRA | AMGEN INC 10% Owner | 0 | $0 | 33,603,948 (Direct) | View |
Ownership | 2023-08-21 7:36 pm | N/A N/A | AMGEN INC | AMGN | Busch Matthew C. VP, Finance & CAO | 0 | $0 | 14,234 (Direct) | View |
2023-08-08 Option Award | 2023-08-10 8:57 pm | N/A N/A | AMGEN INC | AMGN | HOLLEY CHARLES M Director | 153 | $0 | 9,392 (Direct) | View |
2023-08-08 Option Award | 2023-08-10 8:56 pm | N/A N/A | AMGEN INC | AMGN | ISHRAK OMAR Director | 125 | $0 | 3,525 (Direct) | View |